Vortioxetine versus SSRI/SNRI with Pregabalin Augmentation in Treatment-Resistant Burning Mouth Syndrome: A Prospective Clinical Trial

Authors

Stefania Leuci (ORCID: https://orcid.org/0000-0003-4468-5083)
Luca D’Aniello (ORCID: https://orcid.org/0000-0003-1019-9212)
Federica Canfora (ORCID: https://orcid.org/0000-0002-4610-6690)
Gaetano Marenzi (ORCID: https://orcid.org/0000-0002-8255-3391)
Giuseppe Pecoraro (ORCID: https://orcid.org/0000-0002-0705-3442)
Michele Davide Mignogna (ORCID: https://orcid.org/0000-0002-2021-1775)
Noemi Coppola (ORCID: https://orcid.org/0000-0002-0030-3621)
Luca Pellegrini (ORCID: https://orcid.org/0000-0002-2855-2865)
Umberto Albert (ORCID: https://orcid.org/0000-0001-9781-4219)
Daniela Adamo (ORCID: https://orcid.org/0000-0002-3784-4229)
Giulia Ottaviani (ORCID: https://orcid.org/0000-0002-3427-0514)
Massimo Aria (ORCID: https://orcid.org/0000-0002-8517-9411)
Katia Rupel (ORCID: https://orcid.org/0000-0002-6150-9439)